Molina Healthcare, Inc. (MOH) Stock Analysis 2026

This chart shows how MOH's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Molina Healthcare, Inc. trades at a trailing P/E of 1251.81x, generates $700.2M in free cash flow, runs a debt/equity ratio of 94.77, and converts shareholder equity into profit at a -0.2% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

14 analysts covering Molina Healthcare, Inc. currently lean toward a Hold rating, with a mean 12-month price target of $209.12 (+3.3% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Across the 1 valuation model available for MOH, fair value estimates range from $271.31 to $271.31, averaging $271.31 — above the current $202.43 price. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.